BridgeBio Pharma, Inc. (BBIO) NASDAQ

Currency In USD

AD

Valuation

Market Cap15.09B
Enterprise Value17.25B
P/E Ratio-25.38
PEG Ratio-0.77
Price/Sales Ratio15.9
Price/Book Ratio-9.1
Enterprise/Revenue16.91
Enterprise/EBITDA-36.3

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.6
Operating Margin-0.43
AD

Management Effectiveness

Return On Assets-0.26
Return On Equity0.27

Income Statement

Revenue502.08M
Revenue/Share4.82
Gross Profit473.81M
EBITDA-676.45M
Net Income-729.31M
Diluted EPS-3.79

Balance Sheet

Total Cash1.54B
Total Cash/Share7.85
Total Debt2.49B
Total Debt/Equity-1.5
Current Ratio2.09
Book Value Per Share-8.43

Price History

52-Week Change19.41
52-Week High93.42
52-Week Low62.5
Moving Average 50 Days70.22
Moving Average 200 Days72.7

Statistics

Average Volume2.67M
Shares Outstanding194.8M
% Held by Institutions97.98

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split FactorN/A
Last Split DateN/A
AD